Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asprin Dosing Estimator in Healthy Adults
NCT04040465Phase 1Completed
- Sponsor
- University of Utah
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin (9 arms), sponsored by University of Utah. Primary endpoints: Height at 2 weeks, Weight at 2 weeks and 3 more. Started Feb 2021; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT04040465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040465.